{
    "Trade/Device Name(s)": [
        "Clungene Methamphetamine Test",
        "Clungene Morphine Test",
        "Clungene Marijuana Test",
        "CLUNGENE Methamphetamine Tests",
        "CLUNGENE Morphine Tests",
        "CLUNGENE Marijuana Tests"
    ],
    "Submitter Information": "Hangzhou Clongene Biotech Co., Ltd.",
    "510(k) Number": "K153741",
    "Predicate Device Reference 510(k) Number(s)": [
        "K052115"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LDJ",
        "DJC",
        "DJG"
    ],
    "Summary Letter Date": "December 19, 2015",
    "Summary Letter Received Date": "December 28, 2015",
    "Submission Date": "February 22, 2016",
    "Regulation Number(s)": [
        "21 CFR 862.3870",
        "21 CFR 862.3610",
        "21 CFR 862.3650"
    ],
    "Regulation Name(s)": [
        "Cannabinoid test system",
        "Methamphetamine Test",
        "Opiate Test System"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "d-Methamphetamine",
        "Morphine",
        "11-Nor-\u03949-Tetrahydrocannabinol-9-COOH"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [
        "Cassette",
        "Easy Cup",
        "Split Key Cup",
        "Dip Card"
    ],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Immunochromatographic assay",
        "Lateral flow",
        "Competitive binding",
        "Antigen-antibody immunochemistry"
    ],
    "Methodologies": [
        "Lateral flow chromatographic immunoassay",
        "Competitive binding"
    ],
    "Submission Type(s)": [
        "Cassette",
        "Cup",
        "Dip Card"
    ],
    "Document Summary": "FDA 510(k) summary for Clungene Methamphetamine, Morphine, and Marijuana lateral flow immunochromatographic urine tests for drugs of abuse detection",
    "Indications for Use Summary": "Over-the-counter urine tests for preliminary qualitative detection of d-methamphetamine, morphine, and marijuana metabolites, intended as the first step for consumer screening with laboratory confirmatory testing recommended for positive results",
    "fda_folder": "Toxicology"
}